High SVR Rates with 8 and 12 Weeks of Pangenotypic Glecaprevir/Pibrentasvir: Integrated Efficacy and Safety Analysis of Genotype 1-6 Patients without Cirrhosis
dc.contributor.author | Puoti, M | en_US |
dc.contributor.author | Foster, G | en_US |
dc.contributor.author | Wang, S | en_US |
dc.contributor.author | Mutimer, D | en_US |
dc.contributor.author | Gane, E | en_US |
dc.contributor.author | Moreno, C | en_US |
dc.contributor.author | Chang, TT | en_US |
dc.contributor.author | Lee, S | en_US |
dc.contributor.author | Marinho, R | en_US |
dc.contributor.author | Dufour, J | en_US |
dc.contributor.author | Pol, S | en_US |
dc.contributor.author | Hezode, C | en_US |
dc.contributor.author | Gordon, SC | en_US |
dc.contributor.author | Strasser, S | en_US |
dc.contributor.author | Thuluvath, PJ | en_US |
dc.contributor.author | Liu, R | en_US |
dc.contributor.author | Pilot-Matias, T | en_US |
dc.contributor.author | Mensa, F | en_US |
dc.date.accessioned | 2020-07-15T11:04:25Z | |
dc.date.issued | 2017-09-12 | en_US |
dc.identifier.issn | 1424-7860 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/65688 | |
dc.format.extent | 20S - 20S | en_US |
dc.title | High SVR Rates with 8 and 12 Weeks of Pangenotypic Glecaprevir/Pibrentasvir: Integrated Efficacy and Safety Analysis of Genotype 1-6 Patients without Cirrhosis | en_US |
dc.type | Conference Proceeding | |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000447712700072&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 147 | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Centre for Immunobiology [1121]